BIO, Genzyme Working With Sen. Hatch On Orphan Drug Tax Credit Refinement

Legislation that would allow drug companies to begin receiving orphan drug tax credits earlier is being developed by Sen. Hatch (R-Utah) with input from the Biotechnology Industry Organization and Genzyme.